Review article: consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases

Overview of attention for article published in Alimentary Pharmacology & Therapeutics, October 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source
twitter: 43 X users
patent: 1 patent

facebook: 1 Facebook page
reddit: 1 Redditor
guideline: 2 clinical guideline sources

Readers on

mendeley: 257 Mendeley

So far, Altmetric has seen 6 Guidelines that reference this research output.

ACG Clinical Guideline: Management of Crohn's Disease in Adults

Clinical guideline published by American College of Gastroenterology (ACG) on 03 Jun 2025

The American College of Gastroenterology (ACG) provides evidence-based clinical guidelines for gastrointestinal and hepatic conditions, developed by leading experts. Their guidelines aim to enhance patient care through best practices and accessible resources, including a mobile app for on-the-go access.

Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis

Clinical guideline published by Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) on 01 May 2024

The primary objective of GETECCU is to study and research Inflammatory Bowel Disease (IBD) and to seek the standardization of clinical-therapeutic criteria in its diagnosis and treatment.

Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)

Clinical guideline published by Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) on 02 Feb 2024

The primary objective of GETECCU is to study and research Inflammatory Bowel Disease (IBD) and to seek the standardization of clinical-therapeutic criteria in its diagnosis and treatment.

Recommendations by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of patients with inflammatory bowel disease associated with spondyloarthritis

Clinical guideline published by Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) on 01 May 2020

The primary objective of GETECCU is to study and research Inflammatory Bowel Disease (IBD) and to seek the standardization of clinical-therapeutic criteria in its diagnosis and treatment.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity, including 2 additional posts.